John Paul Secrist

Insider Reports History

Entity
Individual
Location
128 Spring Street, Building A, Suite 510, Lexington, MA
Signature
/s/ Andrew Gengos, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Paul Secrist:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cyteir Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 42K Feb 22, 2022 Direct

Insider Reports Filed by John Paul Secrist

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CYT Cyteir Therapeutics, Inc. Feb 22, 2022 1 $0 4 Feb 24, 2022 Chief Scientific Officer
CYT Cyteir Therapeutics, Inc. Jun 17, 2021 0 $0 3 Jun 17, 2021 Chief Scientific Officer